SCHEMBL22737463

SCHEMBL22737463

N#Cc1cccc(C#N)c1-c1cccc2c1c1ccccc1n2-c1ccc(-c2ccccc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.39
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HDAC4 P56524 1/20 0.37
PDE10A Q9Y233 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
KMT2A Q03164 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
MAPK1 P28482 1/20 0.35
ESR2 Q92731 1/20 0.34
HIF1A Q16665 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
GABRA5 P31644 1/20 0.34
GABRA3 P34903 1/20 0.34
IMPDH2 P12268 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22737473 0.92 SMN1; SMN2 (0.38) SMN1; SMN2ALDH1A1LMNAHPGDMAPK1
SCHEMBL22737248 0.92 KDM4E (0.47) KDM4EATML3MBTL1PDE10ASMN1; SMN2
SCHEMBL22737009 0.92 KDM4E (0.43) KDM4EATML3MBTL1HDAC4PDE10A
SCHEMBL22737262 0.91 NR3C1 (0.35) KDM4EATML3MBTL1HDAC4SMN1; SMN2
SCHEMBL22737663 0.90 SMN1; SMN2 (0.37) SMN1; SMN2ALDH1A1LMNAHPGDMAPK1
SCHEMBL22737228 0.90 NR3C1 (0.36) PDE10ASMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL22737371 0.90 GABRG2 (0.35) KDM4EATML3MBTL1SMN1; SMN2KMT2A
SCHEMBL22737462 0.90 ATM (0.37) KDM4EATML3MBTL1PDE10ASMN1; SMN2
SCHEMBL22737393 0.89 SMN1; SMN2 (0.35) KDM4EATML3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL22737388 0.89 KDM4E (0.36) KDM4EATML3MBTL1ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200377490-A1 CONDENSED CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME, AND ELECTRONIC DEVICE INCLUDING ORGANIC LIGHT-EMITTING DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200377490-A1 CONDENSED CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME, AND ELECTRONIC DEVICE INCLUDING ORGANIC LIGHT-EMITTING DEVICE CCNE2, CRY2, PER2 KDM4E 3559/4885ATM 1504/4885L3MBTL1 2024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.